Cumberland Partners Ltd Cuts Stake in McKesson Corporation $MCK

Cumberland Partners Ltd decreased its stake in McKesson Corporation (NYSE:MCK) by 34.0% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 10,440 shares of the company’s stock after selling 5,380 shares during the quarter. Cumberland Partners Ltd’s holdings in McKesson were worth $8,065,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of MCK. Solstein Capital LLC raised its stake in shares of McKesson by 171.4% during the second quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after purchasing an additional 24 shares during the period. State of Wyoming purchased a new position in shares of McKesson in the second quarter valued at $29,000. Hopwood Financial Services Inc. acquired a new stake in McKesson during the 3rd quarter valued at $31,000. Delos Wealth Advisors LLC purchased a new stake in McKesson during the 2nd quarter worth $35,000. Finally, Abound Wealth Management increased its stake in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after buying an additional 24 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Trading Up 0.0%

Shares of MCK opened at $946.52 on Thursday. McKesson Corporation has a 52 week low of $594.34 and a 52 week high of $971.93. The firm has a market cap of $115.94 billion, a price-to-earnings ratio of 27.22, a PEG ratio of 1.52 and a beta of 0.40. The stock has a 50 day moving average of $848.54 and a 200-day moving average of $793.10.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts predict that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is currently 9.43%.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of analyst reports. UBS Group upped their price objective on shares of McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Zacks Research cut McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. increased their price target on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Morgan Stanley reaffirmed an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $943.50.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president directly owned 2,989 shares in the company, valued at $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 794 shares of company stock worth $718,056 over the last quarter. 0.08% of the stock is owned by company insiders.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.